Skip to main content
SpringerLink
Log in
Book cover

The New Dimensions of Warfarin Prophylaxis pp 243–254Cite as

Long-Term Anticoagulant Treatment After Acute Myocardial Infarction

  • Chapter

  • 172 Accesses

Abstract

The results of the Dutch Sixty Plus Reinfarction Study revived the discussion on the effectiveness of long-term oral anticoagulation after myocardial infarction (1,2). This study showed that adequately maintained and sufficiently intensive oral anticoagualtion has a beneficical effect especially on the rate of fatal and nonfatal reinfarction, but also on mortality (1).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sixty Plus Reinfarction Study Research Group. A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1980; ii:989–94.

    Google Scholar 

  2. Mitchell JRA. Anticoagulants in coronary heart disease — retrospect and prospect. Lancet 1981; i: 257–62.

    Article  Google Scholar 

  3. Gorlin R, Fuster V, Ambrose JA. Anatomic-physiologic links between acute coronary syndromes. Circulation 1986; 74: 6–9.

    Article  PubMed  CAS  Google Scholar 

  4. Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council. Assessment of short-term anticoagulant administration after cardiac infarction. Br Med J 1969; 1:335–42.

    Article  Google Scholar 

  5. International Anticoagulant Review Group. Collaborative analysis of long-term anticoagulant administration after acute myocardial infarction. Lancet 1970; i: 203–9.

    Google Scholar 

  6. Merskey C, Drapkin A. Long-term anticoagulant therapy after myocardial infarction. JAMA 1974; 230:208–9.

    Article  PubMed  CAS  Google Scholar 

  7. May GS, Eberlein KA, Furberg C.D, et al. Secondary prevention after myocardial infarction: a review of long-term trials. Prog Cardiovasc Dis 1982; 24:331–52.

    Article  PubMed  CAS  Google Scholar 

  8. Loeliger EA. The optimal therapeutic range in oral anticoagulation: History and proposal. Thromb Haemost 1979; 42:1141–52.

    PubMed  CAS  Google Scholar 

  9. International Committee for Standardization in Haematology and International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. Thromb Haemost 1985; 53:155–6.

    Google Scholar 

  10. Loeliger EA. Anticoagulant therapy in acute myocardial infarction. Am Heart J 1985; 110:1322–3.

    Article  PubMed  CAS  Google Scholar 

  11. Dalen JE, Hirsh J. American College of Chest Physicians and the National Heart, Lung, and Blood Institue National Conference on Antithrombotic Therapy. Arch Intern Med 1986; 146:462–72.

    Article  Google Scholar 

  12. Loeliger EA, Van den Besselaar AMHP, Lewis SM. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control. Thromb Haemost 1985; 53:148–54.

    PubMed  CAS  Google Scholar 

  13. Poller L. Therapeutic ranges in anticoagulant administration. Br Med J 1985; 290: 1683–6.

    Article  CAS  Google Scholar 

  14. Loeliger EA, Poller L, Samama M, et al. Questions and answers on prothrombin time standardization in oral anticoagulant control. Thromb Haemost 1985; 54:515–7.

    PubMed  CAS  Google Scholar 

  15. Hirsh J. Effectiveness of anticoagulants. Sem Thromb Hemost 1986; 12:21–37.

    Article  CAS  Google Scholar 

  16. Goldberg RJ, Gore JM, Dalen JE, Alpert JS. Long-term anticoagulant therapy after acute myocardial infarction. Am Heart J 1985; 109:616–22.

    Article  PubMed  CAS  Google Scholar 

  17. Leizorovicz A, Boissel JP. Oral anticoagulant in patients surviving myocardial infarction. A new approach to old data. Eur J Clin Pharmacol 1983; 24:333–6.

    Article  PubMed  CAS  Google Scholar 

  18. Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council. An assessment of long-term anticoagulant administration after cardiac infarction. Second report. Br Med J 1964; 2: 837–43.

    Article  Google Scholar 

  19. Ebert RV; Borden CW, Hipp HR, et al. Long-term anticoagulant therapy after myocardial infarction. Final report of the Veterans Administration Cooperative Trial. JAMA 1969; 207:2263–6.

    Article  PubMed  CAS  Google Scholar 

  20. Breddin K, Loew D, Lechner K, et al. The German-Austrian Aspirin Trial: A comparison of acetylsalicylic acid, placebo, and phenpro-coumon in secondary prevention of myocardial infarction. Circulation 1980; 62 (suppl. V): V63–V72.

    Google Scholar 

  21. Breddin K, Loew D, Lechner K, et al. Secondary prevention of myocardial infarction: A comparison of acetylsalicylic acid, placebo and phenprocoumon. Haemostasis 1980; 9:325–44.

    PubMed  CAS  Google Scholar 

  22. Bjerkelund C.J. The effect of long-term treatment with dicoumarol in myocardial infarction. Acta Med Scand 1957; 158 (Suppl. 330): 13–212.

    CAS  Google Scholar 

  23. Loeliger EA, Hensen A, Kroes F, et al. A double-blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Med Scand 1967; 182:549–66.

    Article  PubMed  CAS  Google Scholar 

  24. Meuwissen OJAT, Vervoorn AC, Cohen O, et al. Double-blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Med Scand 1969; 186:361–8.

    Article  PubMed  CAS  Google Scholar 

  25. Sørensen OH, Friis T, Jørgensen AW, et al. Anticoagulant treatment of acute coronary thrombosis. Acta Med Scand 1969; 185:65–72.

    Article  PubMed  Google Scholar 

  26. MacMillan RL, Brown KGW, Watt DL. Long-term anticoagulant therapy after myocardial infarction. Can Med Assoc J 1960; 83:567–70.

    PubMed  CAS  Google Scholar 

  27. Harvald B, Hilden T, Lund E. Long-term anticoagulant therapy after myocardial infarction. Lancet 1962; ii:626–30.

    Article  Google Scholar 

  28. Conrad LL, Kyriacopoulos JD, Wiggins CW, Honinck GL. Preventon of recurrences of myocardial infarction. Arch Intern Med 1964; 114:348–58.

    Article  PubMed  CAS  Google Scholar 

  29. Lovell RHH, Denborough MA, Nestel PJ, et al. A controlled trial of long-term treatment with anticoagulant after myocardial infarction in 412 male patients. Med J Aust 1967; 2:97–104.

    PubMed  CAS  Google Scholar 

  30. Seaman AJ, Griswold HE, Beaume RB, Ritzman L. Long-term anticoagulant prophylaxis after myocardial infarction. N Engl J Med 1969; 281: 115–9.

    Article  PubMed  CAS  Google Scholar 

  31. Ritland S, Lygren T. Comparison of efficacy of 3 and 12 months’ anticoagulant therapy after myocardial infarction. Lancet 1969; i:122–4.

    Article  Google Scholar 

  32. Sixty Plus Reinfarction Study Research Group. Risks of long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1982;1:64–8.

    Google Scholar 

  33. Hull R, Hirsh J, Jay R, et al. Different intensities of anticogulation in the long-term treatment of proximal venous thrombosis. N Engl J Med 1982; 307:1676–81.

    Article  PubMed  CAS  Google Scholar 

  34. Whisnant JP, Cartlidge NEF, Elveback LR. Carotid and vertebral-basilar transient ischemic attacks: effect of anticoagulants, hypertension, and cardiac disorders on survival and stroke occurrence — a population study. Ann Neurol 1978; 3:107–15.

    Article  PubMed  CAS  Google Scholar 

  35. Furlan AJ, Whisnant JP, Elveback LR. The decreasing incidence of primary intracerebral hemorrhage: A population study. Ann Neurol 1979; 5:367–73.

    Article  PubMed  CAS  Google Scholar 

  36. Wintzen AR, De Jonge H, Loeliger EA, Bots GTAM. The risk of intracerebral hemorrhage during oral anticoagulant treatment: A population study. Ann Neurol 1984; 16:553–8.

    Article  PubMed  CAS  Google Scholar 

  37. Kase CS, Robinson RK, Stein RW, et al. Anticoagulant — related intracerebral hemorrhage. Neurology 1985; 35:943–8.

    Article  PubMed  CAS  Google Scholar 

  38. Loeliger EA, Van Dijk-Wierda CA, Van den Besselaar AMHP, et al. Anticoagulant control and the risk of bleeding. In: Anticoagulants and Myocardial Infarction: A Reappraisal. Ed. TW Meade. John Wiley and Sons Ltd, Chichester 1984; 135–77.

    Google Scholar 

  39. Errichetti AM, Holden A, Ansell J. Management of oral anticoagulant therapy. Experience with an anticoagulation clinic. Arch Intern Med 1984; 144: 1966–8.

    Article  PubMed  CAS  Google Scholar 

  40. Wright IS, Marple CD, Beck DF. Anticoagulant therapy of coronary thrombosis with myocardial infarction. JAMA 1948; 138: 1074–99.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, University Hospital Leiden and Leiden Thrombosis Centre, the Netherlands

    A. W. Broekmans & E. A. Loeliger

Authors
  1. A. W. Broekmans
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. A. Loeliger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. New York University School of Medicine, New York, New York, USA

    Stanford Wessler

  2. Cornell University Medical College, New York, New York, USA

    Carl G. Becker

  3. Mt. Sinai School of Medicine of the City University of New York, New York, New York, USA

    Yale Nemerson

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer Science+Business Media New York

About this chapter

Cite this chapter

Broekmans, A.W., Loeliger, E.A. (1987). Long-Term Anticoagulant Treatment After Acute Myocardial Infarction. In: Wessler, S., Becker, C.G., Nemerson, Y. (eds) The New Dimensions of Warfarin Prophylaxis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5985-3_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-5985-3_23

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-5987-7

  • Online ISBN: 978-1-4757-5985-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation